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RESEARCH ARTICLE

Open Access

Effect of an herbal/botanical supplement on
recovery from delayed onset muscle soreness: a
randomized placebo-controlled trial
Corey A Rynders2, Judy Y Weltman1, Sara D Rynders3, James Patrie1, John McKnight1, Frank I Katch1, Jay Hertel1
and Arthur Weltman1*

Abstract
Background: We examined the effects of a proprietary herbal/botanical supplement (StemSport, Stemtech, San
Clemente, CA.) suggested to increase circulating stem cells, decrease inflammation, and attenuate exercise induced
muscle damage on recovery from delayed onset muscle soreness (DOMS).
Methods: Sixteen subjects (male = 7, female = 9; age 23.8 ± 10 years; height 171.9 ± 10 cm, mass 72.2 ± 15 kg) were
randomized in a crossover, double-blind, placebo controlled trial to receive a placebo or StemSport supplement
(6150 mg/day) for 14 days. DOMS was induced on day 7 for both placebo and active conditions in the non-dominant
elbow flexor group with repeated eccentric repetitions. Muscle swelling (biceps girth), elbow flexor isometric strength
(hand held dynamometer), muscle pain/tenderness (visual analog scale), range of motion (active elbow flexion and
extension), and inflammation (hsCRP, IL6, and TNF-α) were measured at baseline and at 24 h, 48 h, 72 h, and 168 h
(1 week) post eccentric exercise. The crossover washout period was ≥14 days.
Results: No significant condition-by-time interactions between placebo and StemSport supplementation were
observed with regard to measures of pain (p = 0.59), tenderness (p = 0.71), isometric strength (p = 0.32), elbow flexion
(p = 0.45), muscle swelling (p = 0.90), or inflammation (p > 0.90). Decrements in elbow extension range of motion
48 h post-exercise were less after StemSport supplementation (Δ elbow extension 48 h post; StemSport, −2.0 deg;
placebo, −10 deg; p = 0.003).
Conclusions: These data suggest that compared to placebo, StemSport supplementation does not improve outcome
measures related to muscle recovery after acute upper-arm induced DOMS.
Keywords: DOMS, Blue-green algae, Eccentric exercise

Background
Delayed onset muscle soreness (DOMS) occurs following a bout of unaccustomed exercise in both novice and
experienced athletes. DOMS is associated with muscle
pain, decreased range of motion, muscle fiber disruption,
altered joint kinematics, decreased strength, and acute
tissue damage; each of which contribute to an impairment in future athletic performance and/or predispose
individuals to injury [1,2]. Activities that involve high
force eccentric muscle loading (e.g. plyometric exercises,
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the lowering phase of resistance training, and downhill
running) induce the most severe cases of muscle damage. Symptoms of diffuse pain and tenderness associated
with DOMS typically subside within 5 to 7 days after the
inciting event. As such, studies evaluating the time
course of DOMS typically include post-exercise data collection intervals as long as 168-h (1-wk) into the recovery period.
Delayed onset muscle soreness is a multi-factorial process
and potential mechanistic theories include both anatomical/physiological and biochemical components. For
example, anatomical/physiological mechanisms include
connective tissue damage and muscular micro-trauma,
and biochemical mechanisms include inflammation, and
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oxidative stress. Acute elevations in perceived pain and
tenderness are the result of nociceptor stimulation in
damaged muscle fibers and surrounding connective tissue [3]. Chronic symptoms of pain and tenderness are
likely due to increased intramuscular pressure from the
local pro-inflammatory response (e.g. IL-1β, hsIL-6,
TNF-α, hsCRP, and others) which peaks in the early
phase of recovery and typically persists for 5–7 days
after eccentric exercise [3-5].
Therapeutic modalities for the management of DOMS
related symptoms are numerous and include cryotherapy,
stretching, massage, compression, ultrasound, oral nonsteroidal anti-inflammatory drugs (NSAIDS), and exercise
[2]. In addition, several dietary supplements have been
tested (e.g. protein powders, vitamin C, fish oil, and
chondroitin sulfate) with varying success (see review by
Connolly et al. [6]). The present placebo-controlled
study examined the effects of a proprietary supplement,
StemSport (StemSport, Stemtech, San Clemente, CA.),
on the severity and time course of DOMS following
acute eccentric upper arm exercise. StemSport contains
an extract from the botanical Aphanizomenon flosaquae (AFA; blue-green algae), which has recently been
shown to elevate human bone marrow derived stem
cells [7]. Jensen et al. reported that a novel compound
from AFA binds to the ligand-binding area of human
L-selectin. L-selectin appears to play a role in cell adhesion and the release of bone marrow stem cells into the
circulation [7]. Drapeau et al. recently hypothesized
that bone marrow-derived stem cells may accelerate the
tissue regeneration process in some animal models of
injury and may play a role in recovery from muscle
damaging exercise [8].
StemSport also contains a proprietary blend of herbal antioxidants, and anti-inflammatory substances (Table 1). Preliminary data suggest that supplementation with StemSport
may accelerate tissue repair and restore muscle function
earlier than would occur otherwise [7]. The manufacturer
of StemSport claims that “by assisting in increasing the
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number of adult stem cells in the bloodstream the StemSport concept may help your body naturally repair, rebuild
and recover faster, so you can return to activity and athletic
participation more quickly” [9].
Many commercially available supplements are often promoted without conclusive research demonstrating their efficacy. This present randomized, placebo-controlled, crossover study examined the effects of StemSport supplementation on the inflammatory response, muscle function, and
perceptions of pain and tenderness associated with upper
arm delayed onset muscle soreness (DOMS). We hypothesized that compared to placebo, StemSport would accelerate the rate of DOMS recovery.

Methods
Subjects

Subjects were healthy males (n = 7) and females (n = 9) between the ages 20 and 38 years. Subjects were of normal
weight (mean ± SD, Mass = 72.2 ± 14 kg; Body Fat = 24.4 ±
5%) and not currently participating in a structured resistance or aerobic endurance training program (resistance
exercise was performed ≤ 30 min/day, 1 day/week and low
to moderate aerobic exercise was performed ≤ 30 min/day,
3 days/week; subjects were asked to refrain from performing high intensity exercise resistance/aerobic training for
the duration of the study). Exclusion criteria included a
history of vascular disease, pregnancy, recent injury or
surgery to their non-dominant elbow or upper arm musculature, soft tissue compression complications such as
open wounds/broken skin of the non-dominant shoulder,
arm, wrist or hand, neurological impairments, such as
paresthesia or peripheral neuropathies, circulatory insufficiencies, such as diabetes, hemopheila, thrombophlebitis
or phlebothrombosis, and regular use of over-the-counter
and prescription pain and inflammation medications, or
any agent known to treat the pain and tenderness associated with DOMS. The Institutional Review Board at the
University of Virginia approved the study and subjects
provided written informed consent prior to participation.

Table 1 StemSport ingredient list and purported benefits
Ingredient

Amount per serving

Purported benefit

1. Aphanizomenon flos-aquae extract

1000 mg

Increase the number of circulating stem cells; muscle repair [7,8]

2. Proprietary Herbal/Botanical Blend*

1575 mg

Cats Claw

–

Mangosteen

–

Antioxidant [17]

Rehmannia

–

Anti-inflammatory [18]

Berry extracts

–

Antioxidant

Nattokinase

–

Anti-inflammatory/fibrinolytic [19,20]

Antioxidant [16]

Serrapeptase

–

Anti-inflammatory/fibrinolytic [20]

Curcumin

–

Antioxidant/anti-inflammatory [21,22]

*Specific doses not provided by the manufacturer.
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Design

A study timeline is provided in Figure 1. Subjects were
initially examined by the study physician in the General
Clinical Research Center (GCRC) at UVA to ensure prescreening eligibility. Eligible subjects were given a 14 day
supply of StemSport or a placebo. Subjects and members
of the study team were blinded to the treatment condition. After 7-days of lead-in supplementation, subjects
returned to the GCRC to complete baseline tests of
upper arm swelling, range of motion, and visual analog
scales to evaluate perceptions of elbow flexor pain and
tenderness. Blood samples were obtained for analysis of
highly sensitive C-reactive protein (hsCRP), tissue necrosis
factor-alpha (TNF-α), and interleukin-6 (IL-6). After baseline testing, subjects performed an upper-arm DOMS
exercise protocol. Tests of upper arm swelling, range of
motion, pain and tenderness visual analog scales, and
blood draws were repeated 24 h, 48 h, 72 h, and 168 h
(1 week) after the DOMS exercise protocol in each condition (StemSport/Placebo).
StemSport and placebo supplementation

The StemSport ingredient list is presented in Table 1.
Subjects were instructed to adhere to the following daily
dosing schedule according to manufacturer recommendations: 1000 mg of Aphanizomenon flos-aquae extract
3 times per day in conjunction with food (breakfast,
lunch, and dinner) and 1575 mg of a proprietary herbal/
botanical blend twice per day in conjunction with food
(breakfast and dinner). Prior to the DOMS protocol subjects ingested an extra 1000 mg dose of Aphanizomenon
flos-aquae and an extra 1575 mg dose of the herbal/botanical blend. The extra dose was ingested with water at
least 1-hour prior as per manufacturer instructions. No
food was ingested because the pre-DOMS blood samples
were collected in the fasted state. The placebo was visually similar to StemSport but consisted of a biologically
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inactive substance (1000 mg of encapsulated corn starch).
The time of day that the supplements were taken was
standardized to meal time (e.g. breakfast, lunch, and
dinner). Subjects were required to maintain a pill diary
throughout the study and were instructed to forfeit any
capsules not ingested during the study period. Over-thecounter analgesic and anti-inflammatory medications (i.e.
Tylenol, Advil, Ibuprofen, Motrin, Bextra, Celebrex, etc.)
were prohibited during the supplementation period.
An independent manufacturer (StemSport, Stemtech,
San Clemente, CA.) packaged and the supplements/
placebo. Supplements (placebo/active) were stored and
distributed to subjects by the University Investigational
Pharmacy. None of the members of the study team (except the pharmacist) knew the identity of the supplements
during the study. The order of supplement consumption
(placebo or active) was randomly assigned based on a code
known only to the pharmacist and the study biostatistician.
Pain and tenderness

A pressure algometer (Wagner Instruments, Greenwich,
CT) was used to assess the pressure sensitivity and pain
tolerance of the soft-tissue 5 cm proximal to the elbow
joint line of the biceps brachii muscle. Each subject
received 0.91 kg of compression and recorded their perceived level of pain on a visual analog scale (VAS) from 0–
10, 0 indicating no pain and 10 representing the worst
pain ever experienced. Perceived tenderness of the biceps
brachii was also assessed using the same visual analog
scale. A standard plastic measurement tape with 1 mm
gradations was used to measure the girth of the nondominant arm 5 cm proximal to the elbow joint line.
Biceps peak force

Isomeric elbow flex strength of the dominant arm was
measured at an angle of 90 degrees using a hand-held dynamometer (Hoggan Health Industries, West Jordan, Utah).

Figure 1 Study timeline. Subjects were administered either active or placebo for a 7 day lead in period. After the lead-in period, baseline measures
of muscle function were assessed. Subjects then performed a standardized DOMS protocol for the upper arm. Stemsport/placebo supplementation
continued for 7 days post-DOMS. Muscle function outcome measures were repeated for 3 consecutive days after the DOMS protocol and once again
7 days after the DOMS protocol. Subjects repeated the protocol (opposite condition) after a minimum 14-day washout period.
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The test was performed in the standing position with the
subject’s upper arm resting against a wall to ensure exclusive contraction of the elbow flexors.
Range of motion

A standard goniometer (Model G300, Whitehall Manufacturing, City of Industry, CA) was used to measure the
degrees of active elbow range of motion (extension and
flexion).
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control. Verbal cues were provided throughout the fatigue protocol, including encouragement to exert full
strength and reminders about the minimum three second count. Upon completion of the DOMS protocol,
each subject was provided with an arm sling to secure
the non-dominant arm against the body with the elbow
flexed at 90°. Subjects were asked to wear the sling up to
the start of day 3 (72-hours post-DOMS exercise) and
remove it only to perform activities of daily living (i.e.
bathing, getting dressed, sleeping, driving).

Inflammatory assays

Subjects were fasted at least 6 hours prior to the blood
draws at each time point. They were not allowed to consume any food and/or drink prior to the other baseline
measurements or DOMS protocol. Water consumption
was allowed, but the intake volume was not measured.
TNF-alpha and IL-6 concentrations were measured in
serum using high-sensitivity ELISA assays. The assay
sensitivities were 0.5 pg · ml − 1 for TNF-α and 0.3 ng ·
ml − 1 for IL-6; the mean intra- and interassay coefficients of variation were 6.7% and 13.4% for TNF-α, and
7.4% and 7.8% for hsIL-6. CRP concentrations were
measured by a chemiluminescent assay (Diagnostic
Products Corporation, Immulite 2000, Los Angeles, CA),
the assay sensitivity was 0.1 mg · l − 1 and the mean
intra- and interassay coefficients of variation were 6.7%.
DOMS

After completion of the baseline tests above, subjects
performed an upper arm DOMS protocol as described
by Denegar et al. [10]. Proper positioning, timing, and
form for the DOMs protocol were thoroughly explained
by the study team and subjects were allowed to practice
the protocol with light weights prior to the first supplementation period/actual day of testing. DOMS protocol
prior to actually performing it. A preacher curl bench
with adjustable height was used to isolate the biceps brachii muscle group of the non-dominant arm. Subjects
repetitively performed all eccentric contractions, while
study personnel performed the concentric phase of the
bicep curl. The DOMS protocol was designed to be performed with continuous repetitions until exhaustion (i.e.
there was not a prescription of sets and repetitions and
there was no allotted rest interval within the protocol).
Each subject started with a 15.91 kg dumbbell and performed eccentric contractions until unable to lower the
weight under control over a three second count (if unable to perform one successful repetition with a 15.91 kg
weight, subjects began with a 13.63 kg weight). The
weight decreased in 2.27 kg (5 lbs) increments after a
participant could no longer complete repetitions at a
given weight all the way down to a final weight of
2.27 kg (5 lbs). The DOMS protocol was complete once
the subject was unable to lower a 2.27 kg weight under

Follow-up measures

Measures of pain and tenderness, muscle function, and
blood draws for inflammatory markers were repeated 24hours, 48-hours, 72-hours, and 168-hours (1-week) following DOMS protocol. After the 1-week post-exercise
visit, subjects completed a 14-day washout period and
then repeated the protocol exactly as outlined above with
opposite treatment condition (StemSport or Placebo).
Subjects were asked to maintain similar dietary patterns
throughout the duration of the study.
Statistical analyses

Separate RM-ANOVA models were used to evaluate the
effects of StemSport versus placebo on the primary outcomes. The primary outcome measures were change in
perceived pain and tenderness (VAS scales), change in
edema (girth), change in muscle function (range of motion and biceps peak force), and change in inflammation
(hsCRP, TNF-alpha, and IL-6) 24-hours, 48-hours, 72hours, and 168-hours post-DOMS. Treatment status
(StemSport or placebo) was the between group factor and
time was the within group factor. Baseline (pre-DOMS)
values were used as covariates. Comparisons between conditions were tested by way of a Bonferoni adjusted linear
contrast of means. A p ≤ 0.05 decision rule was utilized as
the null hypothesis rejection criterion for the individual adjusted statistical tests. SAS version 9.2 (SAS Institute Inc,
Cary, NC, USA) was used to conduct the data analyses.

Results
Safety

There were no serious adverse events during the study
period. Subjects reported unusual urine oder (n = 1),
tiredness (n = 1), dry mouth (n = 1), headaches (n = 2),
and nausea (n = 1) while on StemSport supplementation
and tiredness/headaches (n = 1) while on the placebo.
There were no subject dropouts.
Pain and tenderness

Perceived ratings of muscle pain and tenderness were
significantly increased in both conditions for 72 hours
post-exercise (p < 0.001; Figure 2A and B). There were
no differences in pain or tenderness ratings between
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A

B

C

Figure 2 Baseline adjusted comparison of the mean change (±SEM) in (A) elbow flexor pain and (B) tenderness, and (C) biceps girth
between StemSport and placebo at 24, 48, 72 and 168 hours post-DOMS exercise. *Perceived ratings of muscle pain and tenderness were
significantly increased in both conditions for 72 hours post-exercise (p < 0.001; A and B).

conditions at any time point (baseline adjusted comparison
of the mean change in pain and tenderness at 24, 48, 72,
and 168 hours post-exercise, p = 0.99). Biceps girth, a measure of local tissue swelling, was increased for 48-hours
post-exercise in both conditions (p < 0.03; Figure 2C).
Measures of muscle function

Biceps peak force was decreased for 72 hours in both
the placebo (p < 0.02; Figure 3A) and StemSport condition (p < 0.05; Figure 3A). Significant decrements in
elbow extension range of motion were observed for
72 hours during the placebo (p < 0.001; Figure 3B), and
range of motion tended to be reduced during StemSport

supplementation (p < 0.14; Figure 3B). Elbow flexion
range of motion was significantly reduced in both
groups for 72 hours (p < 0.03; Figure 3C). The only significant difference in muscle function between conditions was elbow extension range of motion (placebo, 10
degree decrement in elbow extension range of motion at
48 hours post-exercise versus StemSport, 2 degree decrement in elbow extension range of motion; p = 0.003;
Figure 3B). Overall, less extension range of motion decrement post-exercise was found with supplementation of
StemSport versus the placebo up to 72-hrs post exercise.
All measures of muscle function returned to baseline
values 1 week post-exercise (p > 0.07; Figure 3A-C).
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Figure 3 Baseline adjusted comparison of the mean change (±SEM) in (A) biceps peak force, (B) elbow extension range of motion, and
(C) elbow flexion range of motion between StemSport and placebo at 24, 48, 72 and 168 hours post-DOMS exercise. *p = 0.003,
significantly different from placebo. For biceps peak force, 0.91 kg equates to 2 pounds or 8.9 Newtons.

Inflammatory markers

Complete blood work was completed on 14 of 16 subjects and the data are presented in Figure 4A-C (missing
data due to difficulties with blood draws and laboratory
analysis). Systemic markers of inflammation did not significantly change from baseline values in either condition (hsCRP, p-value for time = 0.24; IL-6, p-value for
time = 0.05; TNF-α, p-value for time = 0.24). There were
no differences between groups for plasma markers of inflammation (p = 0.90).

Discussion
The main finding of the present study is that StemSport
did not accelerate recovery from an acute bout of single
upper-arm eccentric exercise in non-resistance trained
adults.

StemSport contains the fresh water blue-green algae,
AFA, which has been studied primarily for its antioxidant/anti-inflammatory properties [11]. The effects of
AFA on inflammation are limited to animal studies [11].
To our knowledge, the present study is the first to examine the effects of AFA on systemic inflammation and
other markers of DOMS in humans.
Most recently, AFA has been suggested to be a potential bone marrow stem cell mobilizer [7]. Studies from
Jensen et al. (2007) and Drapeau et al. (2010) indicate
that a novel compound from AFA appears to play a role
in the release of bone marrow stem cells into the circulation, and it has been suggested that bone marrowderived stem cells may accelerate the tissue regeneration
process in some animal models of injury [7,8]. It has
been further hypothesized that AFA plays a role in
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Figure 4 Baseline adjusted comparison of the mean change (±SEM) in (A) hsCRP, (B) IL-6, and (C) TNF-α between StemSport and
placebo at 24, 48, 72 and 168 hours post-DOMS exercise.

recovery from muscle damaging exercise via increasing
bone marrow-derived stem cells, although this has not
been tested directly in humans [8].
In a placebo-controlled double-blind crossover study, a
5:1 concentrate of AFA concentrate fed to healthy volunteers (n = 12) produced a 25 ± 1% increase in number of
circulating CD34+ stem cells at 60 minutes (p < 0.0001)
[7]. In contrast, the placebo only produced minor fluctuations in levels of stem cells in the blood circulation over
2 hours. It has been hypothesized that acute increases in
post-exercise circulating levels of stem cells may be beneficial for tissue regeneration and recovery [8]. Stem cell
counts (e.g. CD34+) were not specifically measured in the
present study, however, given that recovery of muscle

function was similar between conditions, it is unlikely that
any AFA induced change in circulating stem cells plays a
major role in recovery from upper arm DOMS.
In agreement with previous studies in the literature,
we did not observe an association between circulating
inflammatory markers and others markers of DOMS
(e.g. pain and tenderness) [12,13]. However, this may
be related to the relatively small muscle mass utilized
in our DOMS protocol which may not have been a potent
stimulus for increasing circulating cytokines. Future studies should attempt to study AFA supplementation in
response to an eccentric exercise protocol designed to
produce a much larger inflammatory response (i.e. downhill running).
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Leukocytes, neutrophils, and monocytes/macrophages
are attracted to damaged tissue within hours of tissue injury and remain present for up to 24 hours, or as has
been shown in macrophages, up to 14 days [14]. Neutrophils and macrophages assist in degradation of damaged
muscle tissue primarily through production of reactive
oxygen and nitrogen species (RONS). Degradation of
damaged tissue is also initiated by the expression of
many local pro- and anti-inflammatory cytokines (e.g.
IL-6, TNF-α, IL-1β, etc.). Circulating IL-6, which has
both pro- and anti-inflammatory functions, is related to
the level of DOMS, and there is some debate as to
whether the post-exercise IL-6 response is required for
muscle adaptation [5]. Elevated levels of IL-6 persist for
at least 48 hours after eccentric upper arm exercise [15].
Less is known about the post-exercise time course of
TNF-α, although studies have detected elevated levels of
TNF-α for up to 5 days during DOMS [15]. The present
data do not support a role of AFA in suppressing circulating levels of IL-6, TNF-α, or CRP in humans in the
basal state or in response to an acute bout of upper arm
eccentric exercise designed to induce DOMS.
Besides AFA, StemSport contains a proprietary blend
of several herbal substances potential antioxidant or
anti-inflammatory properties (Cat’s Claw [16], Mangosteen juice [17], Radix Rehmanniae Preparata [18], Nattokinase [19,20], Serrapeptase and [20], and Curcumin
[21]; see Table 1). For example, Curcumin, an ingredient
derived from the spice Tumeric, has been shown in a
few studies to reduce DOMS related pain and swelling
[17,22] and has a potential role is reducing obesityrelated inflammation. However, our data tend to agree
with the majority of studies in the literature which show
that oral antioxidant supplementation has minimal to no
effect on reducing subjective ratings of pain, tissue swelling, or decrements in muscle function after a bout of eccentric exercise [2,23-25]. It should be noted that data in
the literature now support an inhibitory effect of oral antioxidant supplementation on the skeletal muscle adaptations exercise [26]. In addition, supplementation with the
popular antioxidant ascorbic acid has been shown to delay
the recovery process [24].
A possible limitation of this study was the use of
DOMS to examine the utility of StemSport. It is possible
that the amount of tissue damage associated with the
DOMS protocol may have been too great for StemSport
to have an effect. It is possible that if a less disruptive
regimen was applied (e.g. strength training) StemSport
supplementation may enhance chronic adaptations to
whole body resistance training. Also, future studies may
consider investigating the effects of AFA, independent or
in combination with the other herbal substances. Strengths
include study design (placebo-controlled, double-blinded,
randomized trial) and measurement of both subjective
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markers of DOMS as well as bio-markers of the inflammatory process.

Conclusions
Supplementation with StemSport compared to a placebo
was unable to accelerate recovery from upper arm eccentric exercise. In agreement with the majority of studies in
the literature, dietary supplementation with antioxidant/
anti-inflammatory substances likely provides minimal to
no benefit for reducing the acute symptoms associated
with delayed onset muscle soreness.
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